Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib

Clinical trial NCT00101660 · COMPLETED

Trial details

NCT number: NCT00101660
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia Philadelphia-Positive Myeloid Leukemia

Start date: 2005-02-01
Primary completion: 2006-09-01
Enrollment: 387

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.